1987
Evaluation of circulating malignant cells provides prognostic information in cutaneous T cell lymphoma.
Schechter G, Sausville E, Fischmann A, Soehnlen F, Eddy J, Matthews M, Gazdar A, Guccion J, Munson D, Makuch R. Evaluation of circulating malignant cells provides prognostic information in cutaneous T cell lymphoma. Blood 1987, 69: 841-9. PMID: 3493044, DOI: 10.1182/blood.v69.3.841.bloodjournal693841.Peer-Reviewed Original ResearchConceptsCutaneous T-cell lymphomaT-cell lymphomaBlood involvementLymphocyte morphologyRisk factorsCell lymphomaCTCL cellsIndependent risk factorExtent of diseasePretreatment risk factorsPeripheral blood lymphocyte morphologyUntreated patientsVisceral diseaseWorse survivalLymph nodesInitial diagnosisT stageAggressive featuresSkin stageCutaneous tumorsSkin plaquesPrognostic informationPatientsMalignant cellsMultivariate analysis
1985
Histologic assessment of lymph nodes in mycosis fungoides/sézary syndrome (cutaneous T-cell lymphoma): Clinical correlations and prognostic import of a new classification system
Sausville E, Worsham G, Matthews M, Makuch R, Fischmann A, Schechter G, Gazdar A, Bunn P. Histologic assessment of lymph nodes in mycosis fungoides/sézary syndrome (cutaneous T-cell lymphoma): Clinical correlations and prognostic import of a new classification system. Human Pathology 1985, 16: 1098-1109. PMID: 3876976, DOI: 10.1016/s0046-8177(85)80177-5.Peer-Reviewed Original ResearchConceptsCutaneous T-cell lymphomaLymph node biopsy specimensFive-year survivalLymph node architectureLymph nodesAtypical cellsHistopathologic featuresBiopsy specimensMycosis fungoides/Sézary syndromeLymph node biopsyAtypical lymphoid cellsT-cell lymphomaExtent of skinT-cell regionsLN subgroupAtypical lymphocytesNode biopsySézary syndromeVisceral involvementMycosis fungoidesInitial diagnosisParacortical zonePrognostic valueLN classHistopathologic classification
1984
Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience.
Tester W, Kinsella T, Waller B, Makuch R, Kelley P, Glatstein E, DeVita V. Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience. Journal Of Clinical Oncology 1984, 2: 762-9. PMID: 6547479, DOI: 10.1200/jco.1984.2.7.762.Peer-Reviewed Original ResearchConceptsSecond malignant neoplasmsHodgkin's diseaseMalignant neoplasmsSolid tumorsNational Cancer Institute ExperienceChronic myeloid leukemiaCases of sarcomaRisk of leukemiaUntreated patientsPatient ageHodgkin's lymphomaMedical recordsInstitute experienceMyeloid leukemiaSimilar riskAge 40Treatment groupsPatientsGreater riskLeukemiaTen yearsDiseaseTumorsLymphomaPositive association
1982
Classification of cell lines derived from undifferentiated lymphomas according to their expression of complement and Epstein-Barr virus receptors: Implications for the relationship between African and American Burkitt's lymphoma
Freeman C, Magrath I, Benjamin D, Makuch R, Douglass E, Santaella M. Classification of cell lines derived from undifferentiated lymphomas according to their expression of complement and Epstein-Barr virus receptors: Implications for the relationship between African and American Burkitt's lymphoma. Clinical Immunology 1982, 25: 103-113. PMID: 7151335, DOI: 10.1016/0090-1229(82)90169-6.Peer-Reviewed Original ResearchConceptsEBV nuclear antigenEpstein-Barr virus receptorUndifferentiated lymphomaComplement receptorsExpression of complementEBNA-positive cell linesCell linesVirus receptorAmerican Burkitt's lymphomaCell typesEBV receptorBurkitt's typeReceptor expressionBurkitt's lymphomaNeoplastic counterpartsLymphomaHigh levelsIndividual tumorsVirus producersDegree of expressionNuclear antigenLow levelsReceptorsTumorsEBV